Dr. Julie Bauman, MD
Claim this profileGeorge Washington University Medical Center
Studies Cancer
Studies Squamous Cell Carcinoma
7 reported clinical trials
12 drugs studied
Area of expertise
1Cancer
p16 negative
HPV positive
p16 positive
2Squamous Cell Carcinoma
p16 negative
HPV negative
Stage III
Affiliated Hospitals
Clinical Trials Julie Bauman, MD is currently running
Chemotherapy + Radiation Therapy
for Head and Neck Cancer
This phase II/III trial studies how well radiation therapy works when given together with cisplatin, docetaxel, cetuximab, and/or atezolizumab after surgery in treating patients with high-risk stage III-IV head and neck cancer the begins in the thin, flat cells (squamous cell). Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. Drugs used in chemotherapy, such as cisplatin and docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Cetuximab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. The purpose of this study is to compare the usual treatment (radiation therapy with cisplatin chemotherapy) to using radiation therapy with docetaxel and cetuximab chemotherapy, and using the usual treatment plus an immunotherapy drug, atezolizumab.
Recruiting1 award Phase 2 & 321 criteria
Broccoli Extract
for Tobacco-Related Cancer Risk
This trial tests if an extract from broccoli seeds and sprouts can help heavy smokers by removing harmful substances from their bodies and protecting their cells from damage. Sulforaphane, derived from broccoli seeds and sprouts, has been shown to induce detoxification enzymes and protect against cancer.
Recruiting0 awards Phase 213 criteria
More about Julie Bauman, MD
Clinical Trial Related5 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Julie Bauman, MD has experience with
- Nivolumab
- Cisplatin
- Intensity-Modulated Radiation Therapy
- Abemaciclib
- Cemiplimab-Rwlc
- CUE-101
Breakdown of trials Julie Bauman, MD has run
Cancer
Squamous Cell Carcinoma
Oropharyngeal Carcinoma
Head and Neck Squamous Cell Carcinoma
Head and Neck Cancers
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Julie Bauman, MD specialize in?
Julie Bauman, MD focuses on Cancer and Squamous Cell Carcinoma. In particular, much of their work with Cancer has involved p16 negative patients, or patients who are HPV positive.
Is Julie Bauman, MD currently recruiting for clinical trials?
Yes, Julie Bauman, MD is currently recruiting for 3 clinical trials in Washington District of Columbia. If you're interested in participating, you should apply.
Are there any treatments that Julie Bauman, MD has studied deeply?
Yes, Julie Bauman, MD has studied treatments such as Nivolumab, Cisplatin, Intensity-Modulated Radiation Therapy.
What is the best way to schedule an appointment with Julie Bauman, MD?
Apply for one of the trials that Julie Bauman, MD is conducting.
What is the office address of Julie Bauman, MD?
The office of Julie Bauman, MD is located at: George Washington University Medical Center, Washington, District of Columbia 20037 United States. This is the address for their practice at the George Washington University Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.